Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalteparin Dosing in Superficial Vein Thrombosis
NCT01245998Phase 4Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Dec 2010
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of dalteparin in superficial vein thrombosis (SVT), sponsored by University Medical Centre Ljubljana. Started Dec 2010; status: completed.
02
Drugs
dalteparin
03
Conditions
superficial vein thrombosis (SVT)
Beyond the preview
Go deeper on NCT01245998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01245998.